Stefano Cagnin | Life Science | Best Researcher Award

Posted on by ScienceFather

Prof. Stefano Cagnin | Life Science | Best Researcher Award

Professor at University of Padova, Italy

Prof. Stefano Cagnin is a distinguished researcher and educator in the field of molecular biology and genetics, currently affiliated with the University of Padova. With a robust academic background, including a Ph.D. in Molecular Biology, he specializes in transcriptional analysis across various model organisms such as Homo sapiens, Mus musculus, Drosophila melanogaster, and Sus scrofa. His research focuses on dissecting transcriptional regulation in different pathologies, utilizing innovative bioinformatics and genomics techniques. Prof. Cagnin serves as the Editor-in-Chief of “Biochemical Genetics” and holds editorial positions in several prominent scientific journals. He is actively involved in multiple scientific societies, including the Association for Gene and Cell Therapy and the RNA Society. A prolific contributor to the scientific literature, he has authored numerous publications and has presented his work at international conferences. Through his dedication to advancing knowledge in his field, Prof. Cagnin continues to make significant contributions to the understanding of molecular mechanisms underlying various diseases.

Profile:

Education:

Prof. Stefano Cagnin obtained his educational qualifications in the field of biological sciences, laying a strong foundation for his research career. He earned his Bachelor’s degree in Biological Sciences from the University of Padova, where he developed a keen interest in genetics and molecular biology. Following this, he pursued a Master’s degree in Molecular Biology at the same institution, focusing on the complexities of gene expression and regulation. His academic journey culminated in a Ph.D. in Molecular Biology from the University of Padova, where he conducted extensive research on transcriptional regulation in various model organisms. This comprehensive educational background has equipped him with the necessary skills and knowledge to excel in his research endeavors and contribute significantly to the scientific community.

Professional Experience:

Prof. Stefano Cagnin boasts an extensive professional experience in molecular biology and genetics, with a particular focus on transcriptional analysis and regulatory mechanisms in various model organisms. He is currently a faculty member at the University of Padova, where he has made significant contributions to both research and education. In addition to his teaching responsibilities, he has taken on leadership roles in academic publishing, serving as the Editor-in-Chief of “Biochemical Genetics” and as an Associate Editor for “Molecular Diagnostics and Therapeutics.” His editorial contributions extend to being a member of the editorial boards of several esteemed journals, including “Academia Biology” and “Molecular Therapy – Nucleic Acids.” Prof. Cagnin is also a sought-after reviewer for numerous scientific journals, reflecting his expertise and respect within the academic community. His collaborative work includes leadership in special issues on heart failure and multicellular organism analysis, showcasing his commitment to advancing scientific understanding and innovation in his field.

Research Interests:

Prof. Stefano Cagnin’s research interests are centered on transcriptional analysis and the regulatory mechanisms underlying gene expression in various biological contexts. He employs innovative bioinformatic approaches and advanced molecular biology techniques to dissect transcriptional regulation in Homo sapiens as well as in model organisms such as Mus musculus, Drosophila melanogaster, and Sus scrofa. His work focuses on understanding the implications of these regulatory processes in the context of different pathologies, including muscle atrophy and cancer metastasis. Prof. Cagnin is particularly interested in the role of non-coding RNAs and microRNAs in maintaining cellular functions and interactions, which has significant implications for therapeutic strategies in muscle diseases and cancer. Through his interdisciplinary approach, he aims to advance knowledge in genomics and molecular genetics, contributing to the development of novel therapeutic interventions.

Skills:

Prof. Stefano Cagnin possesses a diverse skill set that encompasses advanced methodologies in molecular biology, bioinformatics, and genomics. He is adept at employing various techniques for transcriptional analysis, allowing for in-depth exploration of gene regulation across different biological systems. His expertise includes the design and implementation of innovative experimental approaches, including engineering biology techniques that integrate molecular and cellular methods. Prof. Cagnin has a strong background in data analysis and interpretation, utilizing computational tools to extract meaningful insights from complex biological datasets. Additionally, he is skilled in scientific communication, having led editorial roles in reputable journals and participated in numerous national and international conferences, where he effectively presents his research findings and collaborates with peers in the field.

Conclusion:

Prof. Stefano Cagnin exemplifies the qualities of a strong candidate for the Best Researcher Award through his extensive editorial contributions, active membership in scientific societies, innovative research in transcriptional analysis, impactful publications, and participation in international conferences. His dedication to advancing scientific knowledge and fostering collaboration in the research community positions him as a deserving nominee for this prestigious award.

Publication Top Noted:

  • SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
    • Authors: E. Pegoraro, E.P. Hoffman, L. Piva, B.F. Gavassini, S. Cagnin, M. Ermani, et al.
    • Journal: Neurology
    • Volume: 76
    • Issue: 3
    • Pages: 219-226
    • Year: 2011
    • Citations: 251
  • The mitochondrial calcium uniporter controls skeletal muscle trophism in vivo
    • Authors: C. Mammucari, G. Gherardi, I. Zamparo, A. Raffaello, S. Boncompagni, et al.
    • Journal: Cell Reports
    • Volume: 10
    • Issue: 8
    • Pages: 1269-1279
    • Year: 2015
    • Citations: 201
  • Overview of electrochemical DNA biosensors: new approaches to detect the expression of life
    • Authors: S. Cagnin, M. Caraballo, C. Guiducci, P. Martini, M. Ross, M. SantaAna, et al.
    • Journal: Sensors
    • Volume: 9
    • Issue: 4
    • Pages: 3122-3148
    • Year: 2009
    • Citations: 179
  • Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions
    • Authors: R.J. Soares, S. Cagnin, F. Chemello, M. Silvestrin, A. Musaro, C. De Pitta, et al.
    • Journal: Journal of Biological Chemistry
    • Volume: 289
    • Issue: 32
    • Pages: 21909-21925
    • Year: 2014
    • Citations: 166
  • Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fiber differentiation
    • Authors: B. Celegato, D. Capitanio, M. Pescatori, C. Romualdi, B. Pacchioni, et al.
    • Journal: Proteomics
    • Volume: 6
    • Issue: 19
    • Pages: 5303-5321
    • Year: 2006
    • Citations: 141
  • A fully electronic sensor for the measurement of cDNA hybridization kinetics
    • Authors: L. Bandiera, G. Cellere, S. Cagnin, A. De Toni, E. Zanoni, G. Lanfranchi, et al.
    • Journal: Biosensors and Bioelectronics
    • Volume: 22
    • Issues: 9-10
    • Pages: 2108-2114
    • Year: 2007
    • Citations: 140
  • Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries
    • Authors: S. Cagnin, M. Biscuola, C. Patuzzo, E. Trabetti, A. Pasquali, P. Laveder, et al.
    • Journal: BMC Genomics
    • Volume: 10
    • Pages: 1-15
    • Year: 2009
    • Citations: 118
  • Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation
    • Authors: L. Iop, A. Bonetti, F. Naso, S. Rizzo, S. Cagnin, R. Bianco, C.D. Lin, P. Martini, et al.
    • Journal: PloS One
    • Volume: 9
    • Issue: 6
    • Article ID: e99593
    • Year: 2014
    • Citations: 99
  • Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages
    • Authors: E. Calura, S. Cagnin, A. Raffaello, P. Laveder, G. Lanfranchi, C. Romualdi
    • Journal: BMC Genomics
    • Volume: 9
    • Pages: 1-20
    • Year: 2008
    • Citations: 82
  • A single cell but many different transcripts: a journey into the world of long non-coding RNAs
    • Authors: E. Alessio, R.S. Bonadio, L. Buson, F. Chemello, S. Cagnin
    • Journal: International Journal of Molecular Sciences
    • Volume: 21
    • Issue: 1
    • Article ID: 302
    • Year: 2020
    • Citations: 68

Hao Chen | Biomedicine | Best Researcher Award

Posted on by ScienceFather

Prof. Hao Chen | Biomedicine | Best Researcher Award

Associate Professor, Chief Physician, Supervisor at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Summary:

Prof. Hao Chen is an accomplished Associate Professor and Chief Physician of Neurosurgery at Shanghai Jiao Tong University School of Medicine, where he also serves as a graduate supervisor. He holds a Doctor of Medicine degree from the same institution and specializes in traumatic brain injury, stroke, and neurocritical care. His research interests include neuromodulation, brain-computer interfaces, and the integration of artificial intelligence in neurosurgery. Prof. Chen has received significant funding for his research, including grants from the National Natural Science Foundation of China. He has been recognized with several awards, including the “Wang Kuancheng” Medical Award and the AANS/CNS BrainLab Neurosurgery Award. Additionally, he is a visiting assistant professor at Vanderbilt University Medical Center and actively participates in professional organizations, contributing to advancements in neurosurgery and medical education. His work has been widely published in leading journals, underscoring his impact in the field.

Profile:

Education:

Prof. Hao Chen completed his Doctor of Medicine at Shanghai Jiao Tong University School of Medicine from September 2013 to July 2017. Prior to this, he earned his Master of Medicine from the same institution between September 2005 and July 2008. His academic journey began at Qingdao University School of Medicine, where he obtained his Bachelor of Clinical Medicine, graduating in July 2005. This comprehensive educational background has equipped him with a strong foundation in medical sciences, particularly in the field of neurosurgery.

Professional Experience:

Prof. Hao Chen has an extensive professional background in neurosurgery and medical education. Currently serving as an Associate Professor and Chief Physician of Neurosurgery at Shanghai Jiao Tong University School of Medicine, he also acts as a graduate supervisor and Vice Director of the Clinical Diagnosis and Treatment Center for Traumatic Brain Injury and Neurocritical Care. In addition to his primary role, Prof. Chen is a visiting assistant professor at Vanderbilt University Medical Center, where he collaborates on advanced research initiatives. He is actively involved in various professional committees, including the Peripheral Nerve Professional Committee of the Chinese Medical Doctor Association, and holds memberships in the American Congress of Neurological Surgeons and the International Brain Injury Association. His clinical expertise encompasses traumatic brain injury, intracerebral hemorrhage, glioblastoma, and neurosurgical intensive care, further demonstrating his commitment to improving patient outcomes and advancing the field of neurosurgery.

Research Interests:

Prof. Hao Chen’s research interests lie at the intersection of neurosurgery and advanced medical technologies. His primary focus includes traumatic brain injury (TBI), stroke, and neurocritical care, where he explores innovative approaches to improve patient management and recovery. He is particularly interested in neuromodulation techniques and the development of brain-computer interfaces that can enhance neurorehabilitation. Additionally, Prof. Chen is actively engaged in integrating artificial intelligence technologies into neurosurgery, aiming to optimize surgical outcomes and refine diagnostic processes. His work seeks to uncover the underlying mechanisms of neurological injuries and develop targeted therapeutic strategies, making significant contributions to the field of neurosurgical research and clinical practice.

Skills:

Prof. Hao Chen possesses a diverse array of skills that are integral to his role as a neurosurgeon and researcher. His clinical expertise encompasses advanced surgical techniques for managing traumatic brain injuries, intracerebral hemorrhages, and glioblastomas, ensuring optimal patient care in high-stakes environments. He is proficient in the application of neurocritical care protocols, emphasizing the importance of comprehensive patient management. In addition to his surgical acumen, Prof. Chen is skilled in utilizing neuromodulation therapies and brain-computer interfaces, showcasing his commitment to integrating innovative technologies into clinical practice. His research capabilities are bolstered by a strong foundation in grant writing, data analysis, and the implementation of clinical trials, enabling him to contribute effectively to the advancement of neurosurgical science and education. Furthermore, his collaborative spirit and leadership qualities foster interdisciplinary teamwork, essential for tackling complex medical challenges.

Conclution:

Prof. Hao Chen’s extensive educational background, current research focus on neurosurgery, substantial funding and awards, active participation in clinical trials, and impactful publications collectively position him as an outstanding candidate for the Research for Best Researcher Award. His dedication to advancing the field of neurosurgery through innovative research and clinical practices significantly contributes to improving patient outcomes and the broader scientific community.

Publication Top Noted:

  • Transplantation of Astrocyte-Derived Mitochondria into Injured Astrocytes Has a Protective Effect Following Stretch Injury
    Authors: Q.-Y. Gong, W. Wang, L. Cai, H. Chen, Z.-M. Xu
    Journal: Mitochondrion
    Volume: 78
    Article Number: 101902
    Year: 2024
  • Endorepellin Downregulation Promotes Angiogenesis After Experimental Traumatic Brain Injury
    Authors: Q. Zhang, Y. Jing, Q. Gong, J. Ding, Z. Xu
    Journal: Neural Regeneration Research
    Volume: 19(5)
    Pages: 1092–1097
    Year: 2024
  • MiR-181b Promotes Angiogenesis and Neurological Function Recovery After Ischemic Stroke
    Authors: L.-X. Xue, L.-Y. Shu, H.-M. Wang, Y.-W. Zhao, H. Chen
    Journal: Neural Regeneration Research
    Volume: 18(9)
    Pages: 1983–1989
    Year: 2023
    Cited by: 5
  • Inhibiting Phosphatase and Actin Regulator 1 Expression is Neuroprotective in the Context of Traumatic Brain Injury
    Authors: Y. Jing, L. Zhang, S.-W. Chen, Z.-M. Xu, J. Ding
    Journal: Neural Regeneration Research
    Volume: 18(7)
    Pages: 1578–1583
    Year: 2023
  • Glucose-Decorated Engineering Platelets for Active and Precise Tumor-Targeted Drug Delivery
    Authors: J. Zhao, Y. Shi, L. Xue, H. Chen, M. Kong
    Journal: Biomaterials Science
    Volume: 11(11)
    Pages: 3965–3975
    Year: 2023
    Cited by: 1
  • Knockout of Sirt2 Alleviates Traumatic Brain Injury in Mice
    Authors: W. Wang, Q.-Y. Gong, L. Cai, H. Chen, H.-L. Tian
    Journal: Neural Regeneration Research
    Volume: 18(2)
    Pages: 350–356
    Year: 2023
    Cited by: 7
  • ACT001 Attenuates Microglia-Mediated Neuroinflammation After Traumatic Brain Injury via Inhibiting AKT/NFκB/NLRP3 Pathway
    Authors: L. Cai, Q. Gong, L. Qi, H. Chen, H. Tian
    Journal: Cell Communication and Signaling
    Volume: 20(1), Article 56
    Year: 2022
    Cited by: 46
  • In Situ Injectable Nano-Complexed Hydrogel Based on Chitosan/Dextran for Combining Tumor Therapy via Hypoxia Alleviation and TAMs Polarity Regulation
    Authors: W. Zhang, Y. Shi, H. Li, H. Chen, M. Kong
    Journal: Carbohydrate Polymers
    Volume: 288
    Article Number: 119418
    Year: 2022
    Cited by: 22
  • Upregulation of C Terminus of Hsc70-Interacting Protein Attenuates Apoptosis and Procoagulant Activity and Facilitates Brain Repair After Traumatic Brain Injury (Retracted)
    Authors: H. Chen, Y. Jing, Z. Xu, H. Tian, L. Xue
    Journal: Frontiers in Neuroscience
    Volume: 14, Article 925
    Year: 2020
    Cited by: 4
  • A Brain-Penetrating Hsp90 Inhibitor NXD30001 Inhibits Glioblastoma as a Monotherapy or in Combination With Radiation
    Authors: H. Chen, Y. Gong, Y. Ma, Z. Cheng, L. Xue
    Journal: Frontiers in Pharmacology
    Volume: 11, Article 974
    Year: 2020
    Cited by: 15